We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
-8.84%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.6B
AUM Growth
-$1.88B
(-13%)
Cap. Flow
-$444M
Cap. Flow
% of AUM
-3.54%
Top 10 Holdings %
Top 10 Hldgs %
48.35%
Holding
1,050
New
210
Increased
412
Reduced
234
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$49.2M |
| 2 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
+$39.8M |
| 3 |
Bath & Body Works
BBWI
|
+$14.7M |
| 4 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
+$14.5M |
| 5 |
PPL
PPL Corp
PPL
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$175M |
| 2 |
Enterprise Products Partners
EPD
|
+$115M |
| 3 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$48.8M |
| 4 |
MPLX
MPLX
|
+$47.4M |
| 5 |
WPZ
Williams Partners L.P.
WPZ
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 56.01% |
| 2 | Healthcare | 3.42% |
| 3 | Financials | 3.23% |
| 4 | Materials | 2.9% |
| 5 | Consumer Discretionary | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENLC
351
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $820K | 0.01% |
55,946
-8,614
| -13% | -$145K |
|
352
Progressive
PGR
$124B
| $819K | 0.01% |
13,434
-191
| -1% | -$10.9K |
|
|
LCI
353
DELISTED
Lannett Company, Inc.
LCI
| $815K | 0.01% |
12,689
+2,254
| +22% | +$174K |
|
|
ABMD
354
DELISTED
Abiomed Inc
ABMD
| $814K | 0.01% |
2,796
-1,406
| -33% | -$356K |
|
|
ESRX
355
DELISTED
Express Scripts Holding Company
ESRX
| $814K | 0.01% |
11,781
+6,615
| +128% | +$505K |
|
|
NCNA
356
NuCana
NCNA
$5.37M
| $809K | 0.01% |
9
+2
| +29% | +$190K |
|
357
CoreCivic
CXW
$3.1B
| $808K | 0.01% |
41,412
+18,187
| +78% | +$393K |
|
358
Lennox International
LII
$18.8B
| $808K | 0.01% |
3,953
-1,038
| -21% | -$216K |
|
359
Quanta Services
PWR
$93.9B
| $803K | 0.01% |
23,365
+10,420
| +80% | +$378K |
|
|
CELG
360
DELISTED
Celgene Corp
CELG
| $797K | 0.01% |
8,939
+3,762
| +73% | +$361K |
|
361
Duke Energy
DUK
$102B
| $796K | 0.01% |
10,271
+5,912
| +136% | +$457K |
|
|
FISV
362
Fiserv Inc
FISV
$27.2B
| $790K | 0.01% |
+11,083
| New | +$779K |
|
363
Extra Space Storage
EXR
$31.2B
| $785K | 0.01% |
8,991
+50
| +0.6% | +$4.21K |
|
|
FPRX
364
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $784K | 0.01% |
45,616
+13,558
| +42% | +$264K |
|
365
Steel Dynamics
STLD
$35.6B
| $770K | 0.01% |
17,408
+3,262
| +23% | +$150K |
|
366
Kura Oncology
KURA
$922M
| $760K | 0.01% |
40,526
+7,043
| +21% | +$137K |
|
|
CBIO
367
Crescent Biopharma
CBIO
$602M
| $747K | 0.01% |
461
+80
| +21% | +$166K |
|
368
Exelixis
EXEL
$13.9B
| $746K | 0.01% |
33,688
+12,785
| +61% | +$353K |
|
369
FedEx
FDX
$74.5B
| $745K | 0.01% |
3,101
+918
| +42% | +$232K |
|
|
RRD
370
DELISTED
RR Donnelley & Sons Co.
RRD
| $741K | 0.01% |
84,913
+37,216
| +78% | +$308K |
|
371
Rhythm Pharmaceuticals
RYTM
$7B
| $728K | 0.01% |
+36,593
| New | +$972K |
|
372
Aclaris Therapeutics
ACRS
$730M
| $725K | 0.01% |
41,369
+7,201
| +21% | +$153K |
|
373
Koppers
KOP
$966M
| $724K | 0.01% |
17,609
+10,877
| +162% | +$478K |
|
374
Cadence Design Systems
CDNS
$90B
| $714K | 0.01% |
19,409
-8,613
| -31% | -$351K |
|
|
EQGP
375
DELISTED
EQGP Holdings, LP
EQGP
| $706K | 0.01% |
30,581
+2,462
| +9% | +$63.4K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ALPS Advisors held 1,050 positions worth $12.6B, down 13% from $14.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $444M in Q1 2018, closing 189 positions and reducing 234 holdings. Its most notable exit was Patterson Companies, Inc., an estimated $48.8M position sold in full.
By sector, the portfolio is most concentrated in Energy at 56% of assets, down from 58% a quarter earlier, followed by Healthcare and Financials.
Against the trend, ALPS Advisors opened a new position in Eli Lilly worth $47.3M.
- ALPS Advisors's largest Q1 2018 buy was Eli Lilly: 611,259 shares worth $47.3M.
- ALPS Advisors added most to Shell Midstream Partners, L.P. in Q1 2018, an estimated $39.8M increase.
- ALPS Advisors's biggest Q1 2018 reduction was Energy Transfer Partners, L.P., cutting an estimated $175M.
- ALPS Advisors fully exited Patterson Companies, Inc. in Q1 2018, selling an estimated $48.8M.
- ALPS Advisors's ten largest holdings make up 48% of its $12.6B portfolio in Q1 2018.
- ALPS Advisors opened 210 new positions and closed 189 in Q1 2018.
- ALPS Advisors's portfolio value fell 13% quarter-over-quarter to $12.6B.
Based on ALPS Advisors's 13F filing for Q1 2018, filed 1 May 2018.